Policy Recommendations for Strengthening the Accelerated Approval Program for Oncology Drugs
Memo: Delivered to the U.S. Food and Drug Administration (FDA)
Substance Use Disorder
Policy
Opportunities to Improve Substance Use Disorder Care in the Federal Health Programs
Comment: Submitted to U.S. Senate Committee on Finance
Print:
On April 23, 2024, the Leonard Davis Institute of Health Economics Substance Use and Harm Reduction Working Group submitted a statement regarding the United States Senate Committee on Finance’s recent hearing “Closing Gaps in the Care Continuum: Opportunities to Improve Substance Use Disorder Care in the Federal Health Programs.” Their comment makes recommendations for improvement in several areas of the care continuum which deserve urgent attention, such as reimbursement for care in a wide range of settings and for certified recovery specialists, improved methadone access, improved wound care and support for harm reduction services.
Views expressed by the researchers are their own and do not necessarily represent those of the University of Pennsylvania Health System (Penn Medicine) or the University of Pennsylvania.
More on Policy at LDI
Estimated Overdose Deaths Due to the One Big Beautiful Bill Act
Letter: Delivered to House Speaker Mike Johnson and Majority Leader John Thune
Health Impacts of SNAP Provisions in the One Big Beautiful Bill Act
Letter: Delivered to House Speaker Mike Johnson and Majority Leader John Thune
Impact of House Budget Reconciliation Bill on Insurance Coverage
Comment: Delivered to the Senate Committee on Health, Education, Labor, and Pensions
Projected Mortality Impacts of the Budget Reconciliation Bill
Letter: Response to Request for Technical Assistance
Loss of Subsidized Drug Coverage and Mortality Following Medicaid Disenrollment: Translating our Findings and Implications for Medicaid Policy
Memo: Supplement to Response to Request for Technical Assistance